IRADIMED CORPORATION (IRMD)

86.38 -0.79% (-0.69)

Over 1M: -5.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

86 88 90 92
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Free Cash Flow: 5.8M Q3 '25 — Net Income: 5.6M Q4 '25 — Free Cash Flow: 5.6M Q4 '25 — Net Income: 6.4M Q1 '26 — Free Cash Flow: 7.9M Q1 '26 — Net Income: 5.8M Q2 '26 — Free Cash Flow: 5.8M Q2 '26 — Net Income: 5.2M 0 2M 4M 6M 8M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

7.9
ROIC 51.0%
OE margin 25.8%
Oper. margin 31.9%
Accruals -3.6%
FCF margin 29.1%
Gross margin 75.9%
OCF margin 31.4%
ROA 20.1%
ROCE 26.0%
ROE 22.7%
OCF / EBIT 0.98×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.9
RPO / sales 0.04×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Current ratio 15.2×
Interest cover —
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 8.1×
F-score 5.6 pts
Payout 68.7%
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.9
Sales CAGR 4Y +19.0%
Sales/sh Y/Y +10.6%
EPS CAGR 4Y +24.0%
Shares change +0.55%
Div. growth +10.0%
EBIT CAGR +17.6%
EBIT Y/Y +15.7%
EPS Y/Y +11.0%
Sales Q/Q +0.28%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.